Bootstrapped PHQ9 categories of ∆@ Pre-Post | Nonresponse (−30 to 30%) | Deterioration (> − 30%) | Differences in proportions from AusBorn group (Bootstrapped p-values) | |||||
---|---|---|---|---|---|---|---|---|
Remission (> 50%) | Minimal Response (30–50%) | Remission | Minimal Response | Nonresponse | Deterioration | |||
NESB MidEast | 64% | 20% | 16% | 0% | .41 | .88 | .56 | .99 |
NESB Europe | 56% | 13% | 25% | 6% | .92 | .19 | .35 | .70 |
NESB Asia | 62% | 22% | 12% | 4% | .18 | .46 | .035 | .67 |
NESB English | 58% | 23% | 14% | 6% | .58 | .16 | .017 | .53 |
ESB English | 61% | 19% | 18% | 3% | .019 | .89 | .073 | .061 |
Aus Born | 56% | 19% | 21% | 5% | – | – | – | – |
Bootstrapped GAD7 categories of ∆@ Pre-Post | Nonresponse | Deterioration | Differences in proportions from AusBorn group (Bootstrapped p-values) | |||||
Remission | Minimal Response | Remission | Minimal Response | Nonresponse | Deterioration | |||
NESB MidEast | 70% | 17% | 13% | 0% | .18 | .88 | .36 | .99 |
NESB Europe | 51% | 24% | 20% | 6% | .42 | .26 | .81 | .79 |
NESB Asia | 68% | 14% | 14% | 4% | .012 | .25 | .093 | .58 |
NESB English | 53% | 17% | 23% | 7% | .39 | .50 | .42 | .11 |
ESB English | 57% | 21% | 19% | 4% | .61 | .20 | .25 | .19 |
Aus Born | 56% | 19% | 21% | 5% | – | – | – | – |